These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats. Löscher W, Hönack D. Eur J Pharmacol; 1993 Jul 20; 238(2-3):191-200. PubMed ID: 8405092 [Abstract] [Full Text] [Related]
11. Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats. Sun W, Wessinger WD. Life Sci; 2004 Aug 06; 75(12):1405-15. PubMed ID: 15240177 [Abstract] [Full Text] [Related]
12. Pharmacological profile of dextrorphan. Fossati A, Vimercati MG, Caputo R, Valenti M. Arzneimittelforschung; 1995 Nov 06; 45(11):1188-93. PubMed ID: 8929237 [Abstract] [Full Text] [Related]
14. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries. Kamel IR, Wendling WW, Chen D, Wendling KS, Harakal C, Carlsson C. J Neurosurg Anesthesiol; 2008 Oct 06; 20(4):241-8. PubMed ID: 18812887 [Abstract] [Full Text] [Related]
15. The spinal anaesthetic effect of dextromethorphan, dextrorphan, and 3-methoxymorphinan. Chen YW, Chen YC, Lin CN, Chu CC, Lin MT, Wang JJ, Kao CH. Eur J Pharmacol; 2007 Aug 27; 569(3):188-93. PubMed ID: 17601557 [Abstract] [Full Text] [Related]
18. Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes. Kerry NL, Somogyi AA, Mikus G, Bochner F. Biochem Pharmacol; 1993 Feb 24; 45(4):833-9. PubMed ID: 8452558 [Abstract] [Full Text] [Related]